Blue Apron Holdings Inc (NYSE: APRN) shares are trading higher on above-average volume Wednesday amid increased retail interest as investors discuss the stock's short-squeeze potential on social media.
Going back to at least December 2014, Biogen Inc (NASDAQ: BIIB) has been diligently working on drugs to cure Alzheimer's disease. Both the negative and positive data revealed over the years have instigated wild price gyrations in the issue.